Our results show that, upon simultaneous recognition of the two antigens, dual split-signaling TIM-3/CLL-1-CAR-T cells potently inhibit LB and LSC viability in vitro and prevent AML engraftment in vivo [161]. This evidence concerns the gene CLEC12A and acute myeloid leukemia.